Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,458 | 927 | 99.8% |
| Education | $31.03 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,474 | 109 | $0 (2024) |
| ABBVIE INC. | $1,414 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,388 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,101 | 91 | $0 (2024) |
| PFIZER INC. | $1,035 | 109 | $0 (2024) |
| Amgen Inc. | $906.49 | 49 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $554.38 | 42 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $488.03 | 25 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $482.80 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $436.65 | 31 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,060 | 61 | ABBVIE INC. ($286.96) |
| 2023 | $1,247 | 81 | ABBVIE INC. ($336.28) |
| 2022 | $1,325 | 97 | ABBVIE INC. ($221.43) |
| 2021 | $2,081 | 135 | AbbVie Inc. ($325.30) |
| 2020 | $1,757 | 101 | AstraZeneca Pharmaceuticals LP ($342.58) |
| 2019 | $2,149 | 154 | AstraZeneca Pharmaceuticals LP ($287.97) |
| 2018 | $1,964 | 142 | AstraZeneca Pharmaceuticals LP ($325.27) |
| 2017 | $1,908 | 160 | Merck Sharp & Dohme Corporation ($275.84) |
All Payment Transactions
931 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Biological | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes Care | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Hepatitis B Vaccine | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: PAIN | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Endocrinology | ||||||
| 07/20/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: VACCINES | ||||||
| 07/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiology | ||||||
| 07/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,379 | 1,717 | $265,809 | $80,055 |
| 2022 | 22 | 1,427 | 1,828 | $259,866 | $75,176 |
| 2021 | 21 | 1,507 | 1,917 | $231,197 | $93,321 |
| 2020 | 20 | 1,462 | 1,862 | $219,355 | $83,485 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 417 | $75,060 | $17,138 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 264 | $35,640 | $10,316 | 28.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 125 | 129 | $14,190 | $9,039 | 63.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 206 | 206 | $56,650 | $8,474 | 15.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 56 | 56 | $16,184 | $7,066 | 43.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $13,125 | $7,043 | 53.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $7,020 | $4,085 | 58.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 129 | 133 | $5,054 | $3,718 | 73.6% |
| 90739 | Hepatitis b vaccine (hepb), cpg-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | Office | 2023 | 13 | 15 | $3,525 | $2,300 | 65.2% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 54 | 57 | $5,130 | $2,173 | 42.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 56 | 56 | $5,040 | $2,097 | 41.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 29 | $10,005 | $1,444 | 14.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 28 | 30 | $3,000 | $905.24 | 30.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $4,845 | $892.28 | 18.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 113 | 117 | $4,797 | $820.04 | 17.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $950.00 | $715.00 | 75.3% |
| G0010 | Administration of hepatitis b vaccine | Office | 2023 | 13 | 15 | $570.00 | $429.00 | 75.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 39 | $1,950 | $390.35 | 20.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,210 | $380.82 | 31.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 15 | $390.00 | $243.00 | 62.3% |
| 90714 | Diphtheria and tetanus vaccine (7 years or older) | Office | 2023 | 12 | 12 | $840.00 | $181.70 | 21.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 12 | $216.00 | $104.72 | 48.5% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $418.00 | $101.08 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 456 | $80,596 | $18,643 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 202 | 324 | $41,564 | $12,231 | 29.4% |
About Dr. Robert Fitz, MD
Dr. Robert Fitz, MD is a Pediatrics healthcare provider based in Union, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447210711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Fitz, MD has received a total of $13,489 in payments from pharmaceutical and medical device companies, with $1,060 received in 2024. These payments were reported across 931 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($13,458).
As a Medicare-enrolled provider, Fitz has provided services to 5,775 Medicare beneficiaries, totaling 7,324 services with total Medicare billing of $332,038. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Union, KY
- Active Since 03/23/2006
- Last Updated 03/17/2021
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1447210711
Products in Payments
- FARXIGA (Drug) $1,001
- VRAYLAR (Drug) $846.27
- TRELEGY ELLIPTA (Drug) $684.99
- Ozempic (Drug) $586.57
- XARELTO (Drug) $453.80
- CHANTIX (Drug) $396.62
- NURTEC ODT (Drug) $360.20
- UBRELVY (Drug) $327.69
- Aimovig (Biological) $322.98
- JARDIANCE (Drug) $312.09
- SHINGRIX (Biological) $215.37
- Vascepa (Drug) $213.44
- Saxenda (Drug) $199.91
- LYRICA (Drug) $198.18
- VYVANSE (Drug) $186.41
- Repatha (Biological) $181.44
- JANUVIA (Drug) $175.23
- SYMBICORT (Drug) $170.09
- MYRBETRIQ (Drug) $166.51
- Victoza (Drug) $164.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Union
Dr. Gretchen Farmer, Md, MD
Pediatrics — Payments: $7,078
Dr. Elizabeth Hammer, M.d, M.D
Pediatrics — Payments: $2,421
Dr. Steven Luke
Pediatrics — Payments: $2,105
Dr. Kayce Strohmeyer, O.d, O.D
Pediatrics — Payments: $2,104
Dr. Elizabeth Panzner, Md,Faap, MD,FAAP
Pediatrics — Payments: $1,958
Dr. Ranjana Ohri Govil
Pediatrics — Payments: $1,942